Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis

Alemtuzumab, an anti-CD52 monoclonal antibody, is effective in the treatment of relapsing–remitting multiple sclerosis (RRMS). Common adverse effects include the development of autoimmune diseases, and Graves’ disease is one of the most frequent presentations. We report here a case of alemtuzumab-in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Immunopathol Pharmacol
Main Authors: Alamo, Angela, Condorelli, Rosita A, La Vignera, Sandro, Calogero, Aldo E
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2019
Fag:
Letter to the Editor
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6458661/
https://ncbi.nlm.nih.gov/pubmed/30968726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2058738419843690
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker